Targeted for corporate purchasing managers, technical directors, and operations leaders, our Boc-(Asp(OBzl)₁₆)-Gastrin I (13‑17) (human) peptide delivers the exact biological activity you need for receptor binding assays, signal‑transduction studies, and drug‑discovery pipelines. Say goodbye to unreliable suppliers, inflated costs, and shipping delays.
1. High Price, Low ROI – Many vendors charge $200‑$350 per mg for a peptide that often fails purity specifications, forcing you to repeat experiments and waste budgets.
2. Inconsistent Quality – Lot‑to‑lot variation in HPLC purity (often <90‑95% instead of ≥98%) leads to unreliable assay data and regulatory setbacks.
3. Slow Delivery Speed – Average lead times of 4‑6 weeks disrupt time‑critical project milestones, especially when you need gram‑scale batches for pre‑clinical studies.
4. Expensive Shipping & Customs – Unclear Incoterms and lack of DDP (Delivered Duty Paid) options result in hidden fees that erode profit margins.
5. Regulatory Uncertainty – Suppliers without GMP, ISO‑9001, or FDA‑registered facilities expose you to compliance risks during IND filing.
Discover how Global Technology Co., Ltd eliminates these pain points
| Parameter | Value |
|---|---|
| Product Name | Boc-(Asp(OBzl)₁₆)-Gastrin I (13‑17) (human) |
| Sequence | Boc‑Asp(OBzl)‑Gly‑Trp‑Met‑Asp‑Phe‑NH₂ (13‑17) |
| Molecular Weight | ≈ 2,200 Da |
| Purity (HPLC) | ≥ 98.5 % |
| Form | Lyophilized powder, amber vial (≤ 5 g) or bulk (≤ 100 g) |
| Storage | -20 °C, desiccated; stable ≥ 24 months |
| Certificates | GMP, ISO 9001, FDA, CE, RoHS |
| MOQ | 1 g (research), 10 g (pilot), 100 g (pre‑clinical) |
| Lead Time | 7‑10 days (≤ 10 g), 14 days (10‑100 g) |
| Price (USD) | $115 / mg (≥ 98.5 % purity) |
Aβ(25-35)-cytotoxic-fragment Acetylgalactosamine Beta-cell-study-peptide-service-and-function Biotin-Galanin-human-product-supplier
Case Study 1 – Oncology Target Validation (USA)
A leading biotech firm used our Boc-(Asp(OBzl)₁₆)-Gastrin I (13‑17) peptide to validate the CCK‑B receptor in pancreatic cancer cell lines. With a 98.7 % pure batch, they achieved a 2.3‑fold increase in assay signal‑to‑noise ratio, cutting assay development time from 8 weeks to 4 weeks.
Case Study 2 – Pre‑clinical Toxicology (EU)
A CRO required 50 g of peptide for 90‑day GLP toxicology. Our fast‑track production delivered 48 g within 12 days, meeting the sponsor’s IND filing deadline and saving an estimated €120,000 in overtime costs.
The MOQ is 1 g for research‑grade orders. For pilot‑scale or pre‑clinical projects, we recommend 10 g or 100 g batches to benefit from lower unit costs.
Yes. Every shipment includes a full CoA with HPLC chromatogram, MALDI‑TOF mass spectrum, residual solvent analysis, and sterility test (if requested). All documents are signed by our GMP‑qualified QA manager.
Absolutely. Our process engineers can modify the Boc‑Asp(OBzl) protecting scheme, adjust peptide length, or provide custom lyophilization cycles to match your downstream formulation.

We ship DDP via UPS or DHL, with real‑time tracking. For urgent projects, express air freight can deliver within 48 hours after production release.
Our technical support team is available 24/7 via email, phone, or WhatsApp. We offer a 30‑day free‑replacement guarantee for any out‑of‑spec batch and a money‑back guarantee if the peptide fails to meet the documented purity.
Limited‑time Offer: Order within the next 48 hours and receive a FREE 0.5 g sample plus complimentary logistics planning.
Or call us directly at +86 199 4383 0844 (We speak English and Mandarin)
John Miller, Procurement Manager, BioGenX (USA)
“The price was 30% lower than our previous supplier, and the purity exceeded expectations. We placed a repeat order within two weeks.”
Dr. Emily Rodriguez, Technical Director, Horizon Therapeutics (Canada)
“Fast 7‑day delivery allowed us to meet our IND deadline. The CoA was clear, and the support team answered every technical query within hours.”
Mark Chen, Operations Manager, Nova Biolabs (EU)
“We appreciated the DDP shipping – no hidden customs fees. The peptide performed perfectly in our high‑throughput screening.”
Trusted by Industry Leaders Worldwide
Client Logo Wall (selected) – Global Pharma Inc., BioGenX, MedTech Solutions, Horizon Therapeutics, Nova Biolabs
Certificates & Compliance – CE, FDA, GMP, ISO 9001, RoHS, VDE, CB, GS, SAA, HACCP/GMP, IPPC – all verified by third‑party auditors (see attached PDF on request).
Contact our compliance team for documentation